Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4jbq | VX6 | Aurora kinase A | 2.7.11.1 | 1.000 | |
| 4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.624 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.570 | |
| 4o0u | ADN | Aurora kinase A | 2.7.11.1 | 0.567 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.563 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.553 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.543 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.535 | |
| 3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.521 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.512 | |
| 3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.510 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.510 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.509 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.509 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.508 | |
| 2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.507 | |
| 2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.506 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.505 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.504 | |
| 2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.503 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.503 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.500 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.495 | |
| 4c3p | ACP | Aurora kinase A | 2.7.11.1 | 0.493 | |
| 1ol7 | ADP | Aurora kinase A | 2.7.11.1 | 0.492 | |
| 2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.492 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.491 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.491 | |
| 5dos | ATP | Aurora kinase A | 2.7.11.1 | 0.489 | |
| 5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.489 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.488 | |
| 3uo5 | 0BX | Aurora kinase A | 2.7.11.1 | 0.487 | |
| 4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.486 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
| 5dn3 | ATP | Aurora kinase A | 2.7.11.1 | 0.486 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.485 | |
| 4wsq | KSA | AP2-associated protein kinase 1 | 2.7.11.1 | 0.485 | |
| 2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.484 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.484 | |
| 4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.484 | |
| 2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.483 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.483 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.482 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.480 | |
| 5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.480 | |
| 3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.479 | |
| 4fg8 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.479 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
| 2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.478 | |
| 2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.478 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.478 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.478 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.477 | |
| 3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.477 | |
| 5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.475 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.474 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.474 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.474 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.473 | |
| 3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.473 | |
| 1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.472 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.472 | |
| 3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.471 | |
| 4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.471 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.471 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.471 | |
| 4dea | NHI | Aurora kinase A | 2.7.11.1 | 0.470 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.469 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.469 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 3bfb | 9OD | Pheromone-binding protein ASP1 | / | 0.469 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.469 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.469 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.468 | |
| 2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.468 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.468 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.468 | |
| 1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.467 | |
| 3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.467 | |
| 5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.467 | |
| 5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.467 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.465 | |
| 3w16 | P9J | Aurora kinase A | 2.7.11.1 | 0.465 | |
| 4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.465 | |
| 4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.465 | |
| 2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.464 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.464 | |
| 3gyi | FAD | Cholesterol oxidase | 1.1.3.6 | 0.464 | |
| 1cc2 | FAD | Cholesterol oxidase | 1.1.3.6 | 0.463 | |
| 1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.463 | |
| 3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.463 | |
| 5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.463 | |
| 5dr2 | ATP | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.462 | |
| 2xne | ASH | Aurora kinase A | 2.7.11.1 | 0.462 | |
| 2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.462 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.462 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.462 | |
| 1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.461 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.461 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
| 2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
| 3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.461 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.461 | |
| 2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.460 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.460 | |
| 2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
| 3slk | NDP | Polyketide synthase extender module 2 | / | 0.460 | |
| 3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.460 | |
| 1n4u | FAE | Cholesterol oxidase | 1.1.3.6 | 0.459 | |
| 1ot7 | CHC | Bile acid receptor | / | 0.459 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.459 | |
| 4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.459 | |
| 4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.459 | |
| 1pyx | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.458 | |
| 2aaz | CB3 | Thymidylate synthase | 2.1.1.45 | 0.458 | |
| 3f5p | 741 | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.458 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.458 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
| 4a4v | YFD | Peroxisome proliferator-activated receptor gamma | / | 0.458 | |
| 5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.458 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
| 4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.457 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.456 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
| 4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.456 | |
| 4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.456 | |
| 4qi4 | FAD | Cellobiose dehydrogenase | / | 0.456 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.456 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.455 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 4jaj | XU1 | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.454 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 2bmc | MPY | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.454 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.454 | |
| 3ori | AGS | Serine/threonine protein kinase | / | 0.454 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 4g7g | VFV | Lanosterol 14-alpha-demethylase | / | 0.454 | |
| 4mf0 | 29Z | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.454 | |
| 5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.454 | |
| 1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.453 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.453 | |
| 2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.453 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.453 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
| 4qi7 | FAD | Cellobiose dehydrogenase | / | 0.453 | |
| 4rek | FAD | Cholesterol oxidase | 1.1.3.6 | 0.453 | |
| 1b8s | FAD | Cholesterol oxidase | 1.1.3.6 | 0.452 | |
| 1hdc | CBO | 3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase | 1.1.1.53 | 0.452 | |
| 1osv | CHC | Bile acid receptor | / | 0.452 | |
| 2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.452 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.452 | |
| 4b7x | NAP | Probable oxidoreductase | / | 0.452 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.452 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.451 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.451 | |
| 3g49 | NAP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.451 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
| 3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.451 | |
| 4c3r | ACP | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
| 5dmz | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.451 | |
| 1drb | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
| 2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.450 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.450 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.450 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.450 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.450 | |
| 4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.449 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.449 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
| 2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.449 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.449 | |
| 4qec | NAP | ElxO | / | 0.449 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.449 | |
| 1dxq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.448 | |
| 1ha3 | MAU | Elongation factor Tu-A | / | 0.448 | |
| 1ie8 | KH1 | Vitamin D3 receptor | / | 0.448 | |
| 2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.448 | |
| 2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.448 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
| 3t14 | FAD | Sulfide-quinone reductase | / | 0.448 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.448 | |
| 3zia | ATP | ATP synthase subunit alpha, mitochondrial | / | 0.448 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.448 | |
| 5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.448 | |
| 1a72 | PAD | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.447 | |
| 1ol6 | ATP | Aurora kinase A | 2.7.11.1 | 0.447 | |
| 3bfa | 9OD | Odorant binding protein ASP1 | / | 0.447 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.447 | |
| 3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
| 3t2z | FAD | Sulfide-quinone reductase | / | 0.447 | |
| 4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.447 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.447 | |
| 4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
| 4q71 | FAD | Bifunctional protein PutA | / | 0.447 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 1gg5 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.446 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.446 | |
| 1q8y | ADP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.446 | |
| 1qbu | 846 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
| 3h1v | TK1 | Glucokinase | 2.7.1.2 | 0.446 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.446 | |
| 3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.446 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 1h69 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.445 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
| 2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
| 2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.445 | |
| 4bge | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.445 | |
| 4bgi | I4I | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.445 | |
| 4f07 | FAD | Styrene monooxygenase component 2 | / | 0.445 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.445 | |
| 4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.445 | |
| 4qi5 | FAD | Cellobiose dehydrogenase | / | 0.445 | |
| 1e3e | NAI | Alcohol dehydrogenase 4 | 1.1.1.1 | 0.444 | |
| 2gtk | 208 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 3h86 | AP5 | Adenylate kinase | / | 0.444 | |
| 3p3e | 3P3 | UDP-3-O-acyl-N-acetylglucosamine deacetylase | / | 0.444 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.444 | |
| 3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.444 | |
| 4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.444 | |
| 4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.444 | |
| 4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.444 | |
| 4xxg | FAD | Cholesterol oxidase | 1.1.3.6 | 0.444 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.443 | |
| 1mq4 | ADP | Aurora kinase A | 2.7.11.1 | 0.443 | |
| 1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 2hfp | NSI | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 2q5p | 241 | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
| 3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.443 | |
| 3zep | 1NX | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.443 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.443 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.443 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.443 | |
| 4xum | IMN | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.443 | |
| 5eb5 | FAD | (R)-mandelonitrile lyase 1 | 4.1.2.10 | 0.443 | |
| 1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.442 | |
| 1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.442 | |
| 1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.442 | |
| 3jyn | NDP | Quinone oxidoreductase | / | 0.442 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.442 | |
| 4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 4lrj | ANP | Uncharacterized protein | / | 0.442 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.442 | |
| 4yry | FAD | Glutamate synthase, beta subunit | / | 0.442 | |
| 1kkq | 471 | Peroxisome proliferator-activated receptor alpha | / | 0.441 | |
| 2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.441 | |
| 2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 2ft9 | CHD | Fatty acid-binding protein 2, liver | / | 0.441 | |
| 2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.441 | |
| 2rbe | NDP | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
| 2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.441 | |
| 3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.441 | |
| 3f46 | I2C | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.441 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.441 | |
| 4n6b | COA | Uncharacterized protein | / | 0.441 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
| 1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.440 | |
| 1zhw | HC2 | Oxysterol-binding protein homolog 4 | / | 0.440 | |
| 2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.440 | |
| 3sgx | 0FW | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.440 | |
| 3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.440 | |
| 4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.440 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.440 | |
| 4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
| 4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.440 | |
| 4fsm | HK1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4g3j | VNT | Lanosterol 14-alpha-demethylase | / | 0.440 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
| 4u2s | FDA | Cholesterol oxidase | 1.1.3.6 | 0.440 | |
| 4zoh | FAD | Putative oxidoreductase FAD-binding subunit | / | 0.440 | |
| 5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 |